← Leaderboards
David A Sullivan
Schepens Eye Research Institute
$9,500,346
Attributed
$9,500,346
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $702.1K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$9,500,346 · 2
By mechanism
R01$8,958,596 · 1
R21$541,750 · 1
Top collaborators
No co-investigators on record.
Most similar at Schepens Eye Research Institute
Same institution · by research overlap
- Daniel Raphael Saban$11,073,426
- Darlene A Dartt$22,271,016
- Ilene K. Gipson$11,024,212
- Juan Ding$89,466
Others in their field
Top investigators on “Androgens”
- Shalendar Bhasin · La Biomed Res Inst/ Harbor Ucla Med Ctr$36,153,267
- Charles L Sawyers · Sloan-Kettering Inst Can Research$24,511,314
- Susan E. Hankinson · University Of Massachusetts Amherst$24,278,267
- Brian E Henderson · University Of Southern California$20,677,861
- Cory Abate-Shen · Columbia University Health Sciences$20,094,849
- Diane E Merry · Thomas Jefferson University$17,810,180
Research focus
AndrogensPostmenopauseIn Situ HybridizationChronicTissuesPharmaceutical PreparationsOcular SurfaceLeadMeibomian Gland DysfunctionPlayProductionRegulationEvaporationFilmFunctional DisorderCorneaLipidsEpithelial CellsPreventMouse ModelAqueousAndrogen AntagonistsCommunicable DiseasesClinical Treatment
Grant awards (18)
Cationic Amphiphilc Drugs for the Treatment of Meibomian Gland Dysfunction$246,250
R21 · FY2019 · EY · contact PI
Cationic Amphiphilc Drugs for the Treatment of Meibomian Gland Dysfunction$295,500
R21 · FY2018 · EY · contact PI
Sex, sex steroids and dry eye syndromes$624,439
R01 · FY2014 · EY · contact PI
Sex, sex steroids and dry eye syndromes$605,325
R01 · FY2013 · EY · contact PI
Sex, sex steroids and dry eye syndromes$637,183
R01 · FY2012 · EY · contact PI
Sex, sex steroids and dry eye syndromes$639,099
R01 · FY2011 · EY · contact PI
Sex, sex steroids and dry eye syndromes$688,977
R01 · FY2010 · EY · contact PI
Sex, sex steroids and dry eye syndromes$675,667
R01 · FY2009 · EY · contact PI
Sex, sex steroids and dry eye syndromes$624,219
R01 · FY2008 · EY · contact PI
Sex, sex steroids and dry eye syndromes$618,413
R01 · FY2007 · EY · contact PI
Sex, sex steroids and dry eye syndromes$618,331
R01 · FY2006 · EY · contact PI
Gender, sex steroids and dry eye syndromes$639,552
R01 · FY2005 · EY
Gender, sex steroids and dry eye syndromes$62,540
R01 · FY2005 · EY
Gender, sex steroids and dry eye syndromes$589,244
R01 · FY2004 · EY
Gender, sex steroids and dry eye syndromes$572,080
R01 · FY2003 · EY
Gender, sex steroids and dry eye syndromes$519,585
R01 · FY2002 · EY
GENDER, SEX STEROIDS AND DRY EYE SYNDROMES$428,208
R01 · FY2001 · EY
GENDER, SEX STEROIDS AND DRY EYE SYNDROMES$415,734
R01 · FY2000 · EY